BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 1314394)

  • 1. DNA binding and transcriptional regulatory activity of mammalian achaete-scute homologous (MASH) proteins revealed by interaction with a muscle-specific enhancer.
    Johnson JE; Birren SJ; Saito T; Anderson DJ
    Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3596-600. PubMed ID: 1314394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different E-box regulatory sequences are functionally distinct when placed within the context of the troponin I enhancer.
    Yutzey KE; Konieczny SF
    Nucleic Acids Res; 1992 Oct; 20(19):5105-13. PubMed ID: 1329039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MyoD and achaete-scute: 4-5 amino acids distinguishes myogenesis from neurogenesis.
    Davis RL; Cheng PF; Lassar AB; Thayer M; Tapscott S; Weintraub H
    Princess Takamatsu Symp; 1989; 20():267-78. PubMed ID: 2562185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel myogenic regulatory circuit controls slow/cardiac troponin C gene transcription in skeletal muscle.
    Parmacek MS; Ip HS; Jung F; Shen T; Martin JF; Vora AJ; Olson EN; Leiden JM
    Mol Cell Biol; 1994 Mar; 14(3):1870-85. PubMed ID: 8114720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E1A-mediated inhibition of myogenesis correlates with a direct physical interaction of E1A12S and basic helix-loop-helix proteins.
    Taylor DA; Kraus VB; Schwarz JJ; Olson EN; Kraus WE
    Mol Cell Biol; 1993 Aug; 13(8):4714-27. PubMed ID: 8393137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The MyoD DNA binding domain contains a recognition code for muscle-specific gene activation.
    Davis RL; Cheng PF; Lassar AB; Weintraub H
    Cell; 1990 Mar; 60(5):733-46. PubMed ID: 2155707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple regulatory elements contribute differentially to muscle creatine kinase enhancer activity in skeletal and cardiac muscle.
    Amacher SL; Buskin JN; Hauschka SD
    Mol Cell Biol; 1993 May; 13(5):2753-64. PubMed ID: 8474439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mos activates myogenic differentiation by promoting heterodimerization of MyoD and E12 proteins.
    Lenormand JL; Benayoun B; Guillier M; Vandromme M; Leibovitch MP; Leibovitch SA
    Mol Cell Biol; 1997 Feb; 17(2):584-93. PubMed ID: 9001211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the DNA-binding properties of MyoD, myogenin, and E12 by fluorescence anisotropy.
    Maleki SJ; Royer CA; Hurlburt BK
    Biochemistry; 2002 Sep; 41(35):10888-94. PubMed ID: 12196028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional activation domain of the muscle-specific gene-regulatory protein myf5.
    Braun T; Winter B; Bober E; Arnold HH
    Nature; 1990 Aug; 346(6285):663-5. PubMed ID: 2385294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue-specific gene activation by MyoD: determination of specificity by cis-acting repression elements.
    Weintraub H; Genetta T; Kadesch T
    Genes Dev; 1994 Sep; 8(18):2203-11. PubMed ID: 7958889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction and repression of mammalian achaete-scute homologue (MASH) gene expression during neuronal differentiation of P19 embryonal carcinoma cells.
    Johnson JE; Zimmerman K; Saito T; Anderson DJ
    Development; 1992 Jan; 114(1):75-87. PubMed ID: 1576967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential trans-activation of a muscle-specific enhancer by myogenic helix-loop-helix proteins is separable from DNA binding.
    Chakraborty T; Brennan T; Olson E
    J Biol Chem; 1991 Feb; 266(5):2878-82. PubMed ID: 1847137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of fgf4 gene expression in the myotomes is regulated by myogenic bHLH factors and by sonic hedgehog.
    Fraidenraich D; Iwahori A; Rudnicki M; Basilico C
    Dev Biol; 2000 Sep; 225(2):392-406. PubMed ID: 10985858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The MCK enhancer contains a p53 responsive element.
    Weintraub H; Hauschka S; Tapscott SJ
    Proc Natl Acad Sci U S A; 1991 Jun; 88(11):4570-1. PubMed ID: 1647009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A splice variant of the ITF-2 transcript encodes a transcription factor that inhibits MyoD activity.
    Skerjanc IS; Truong J; Filion P; McBurney MW
    J Biol Chem; 1996 Feb; 271(7):3555-61. PubMed ID: 8631961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acquisition of myogenic specificity by replacement of three amino acid residues from MyoD into E12.
    Davis RL; Weintraub H
    Science; 1992 May; 256(5059):1027-30. PubMed ID: 1317057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscle gene E-box control elements. Evidence for quantitatively different transcriptional activities and the binding of distinct regulatory factors.
    Apone S; Hauschka SD
    J Biol Chem; 1995 Sep; 270(36):21420-7. PubMed ID: 7673178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paired MyoD-binding sites regulate myosin light chain gene expression.
    Wentworth BM; Donoghue M; Engert JC; Berglund EB; Rosenthal N
    Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1242-6. PubMed ID: 1847512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A gene with homology to the myc similarity region of MyoD1 is expressed during myogenesis and is sufficient to activate the muscle differentiation program.
    Edmondson DG; Olson EN
    Genes Dev; 1989 May; 3(5):628-40. PubMed ID: 2473006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.